Improvement of multiple organ functions in hepatorenal syndrome during albumin dialysis with the molecular adsorbent recirculating system

被引:79
作者
Mitzner, SR
Klammt, S
Peszynski, P
Hickstein, H
Korten, G
Stange, J
Schmidt, R
机构
[1] Univ Rostock, Dept Med, Div Nephrol, D-18055 Rostock, Germany
[2] Univ Rostock, Dept Med, Div Gastroenterol, D-18055 Rostock, Germany
来源
THERAPEUTIC APHERESIS | 2001年 / 5卷 / 05期
关键词
artificial liver support; albumin dialyis molecular adsorbent recirculating system; hepatorenal syndrome;
D O I
10.1046/j.1526-0968.2001.00388.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recently, significant improvement of renal function and prolongation of survival were reported in hepatorenal syndrome (HRS) patients treated with the Molecular Adsorbent Recirculating System (MARS). As no impact on extrarenal organ function was documented, this trial looked into multiple organ function changes during MARS in HRS patients. Eight HRS patients (4 mate, mean age 42. 1 years, range 30-58, all United Network for Organ Sharing [UNOS] status 2A) were treated intermittendly 4-14 times (total 47, mean 5.9 +/- 3.4) between 4 and 8 h/single treatment. The following changes were observed pre- and posttreatment: bilirubin 466 +/- 146 to 284 +/- 134 gammamol/L, creatinine 380 +/- 182 to 163 +/- 119 mumol/L, urea 26.4 +/- 10.3 to 12.9 +/- 4.9 mmol/L, plasma sodium 127.5 +/- 7.7 to 137.5 +/- 4.8 mmol/L (all p < 0.01). Mean arterial pressure (MAP) increased from 71.9 +/- 12.8 to 95.6 +/- 7.8 Torr (p < 0.001). Oliguria or anuria, present in all patients, was successfully reverted. Ascites, present in all patients, was not detectable after the treatment period. The hepatic encephalopathy grade decreased from 2.8 +/- 0.8 to 0.8 +/- 0.7 (p < 0.0001). Child-Index decreased from 13.25 +/- 1.3 to 9.4 +/- 1.8 (p < 0.001). The hospital survival rate was 62%. One man underwent successful liver transplantation 18 months after the treatment. We conclude that MARS can improve multiple organ functions in patients with HRS.
引用
收藏
页码:417 / 422
页数:6
相关论文
共 30 条
[1]   Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis [J].
Arroyo, V ;
Gines, P ;
Gerbes, AL ;
Dudley, FJ ;
Gentilini, P ;
Laffi, G ;
Reynolds, TB ;
RingLarsen, H ;
Scholmerich, J .
HEPATOLOGY, 1996, 23 (01) :164-176
[2]  
AWAD SS, 2001, IN PRESS SURGERY
[3]   THE NITRIC-OXIDE HYPOTHESIS AND THE HYPERDYNAMIC CIRCULATION IN CIRRHOSIS [J].
BOMZON, A ;
BLENDIS, LM .
HEPATOLOGY, 1994, 20 (05) :1343-1350
[4]  
Epstein M., 1996, KIDNEY LIVER DIS, P75
[5]  
Hartleb M, 1997, ACTA GASTRO-ENT BELG, V60, P222
[6]  
Huster D, 2001, Z Gastroenterol, V39 Suppl 2, P13, DOI 10.1055/s-2001-919024
[7]  
Jalan R, 2001, Z Gastroenterol, V39 Suppl 2, P12, DOI 10.1055/s-2001-919023
[8]  
JOST U, 2001, Z GASTROENTEROL S2, V39, P43
[9]  
KAUFMANN MA, 1995, J PHARMACOL EXP THER, V273, P855
[10]   RISK-FACTORS AND OUTCOME OF 107 PATIENTS WITH DECOMPENSATED LIVER-DISEASE AND ACUTE-RENAL-FAILURE (INCLUDING 26 PATIENTS WITH HEPATORENAL-SYNDROME) - THE ROLE OF HEMODIALYSIS [J].
KELLER, F ;
HEINZE, H ;
JOCHIMSEN, F ;
PASSFALL, J ;
SCHUPPAN, D ;
BUTTNER, P .
RENAL FAILURE, 1995, 17 (02) :135-146